Summary
This 8-K filing from CRH Public Limited Company (CRH) on September 28, 2007, primarily serves as a notification of transactions by a Director/Person Discharging Managerial Responsibility (PDMR). Specifically, it details shareholding changes for Mr. William P. Egan, a director of CRH. The core of the filing is the purchase of CRH ordinary shares by Mr. Egan. This transaction involves both beneficial and non-beneficial interests, indicating a significant personal investment in the company by a key executive. Investors should note the details of the purchase, including the number of shares acquired and the price paid, as this can provide insights into insider confidence and the executive's view of the company's valuation.
Key Highlights
- 1Notification of Director/PDMR shareholding transaction by William P. Egan.
- 2Mr. Egan acquired shares for both beneficial and non-beneficial interests.
- 3Beneficial interest acquisition: 5,000 ordinary shares.
- 4Non-beneficial interest acquisition: 12,000 ordinary shares.
- 5Purchase price for beneficial interest: US$38.562 per share.
- 6Purchase price for non-beneficial interest: US$38.585 per share.
- 7The transaction occurred on September 26, 2007, on the New York Stock Exchange.
Frequently Asked Questions
William P. Egan is identified as a director of CRH and a person discharging managerial responsibilities (PDMR). This filing concerns his personal shareholding activities within the company.
Mr. Egan purchased CRH ordinary shares. This included acquiring a beneficial interest of 5,000 shares at US$38.562 per share and a non-beneficial interest of 12,000 shares at US$38.585 per share.
A 'beneficial interest' means Mr. Egan directly owns and can benefit from the shares. A 'non-beneficial interest' typically implies that while the shares may be held in trust or by nominees, Mr. Egan has some form of indirect control or a vested interest in them, though not direct ownership for personal gain.
Following this transaction, Mr. Egan has a total beneficial holding of 15,000 shares (including 10,000 held as ADRs) and a total non-beneficial holding of 12,000 shares (held as ADRs).